Frederik Groenewegen
InvestorGeneral Partner at 415 Capital · Board director at R3 Vascular
Germany
Writes $100K – $5M checks · typically $1.5M
About
Frederik Groenewegen is a co-founder and General Partner of 415C, focusing on medical technology investments. Before starting the firm, he was a Business Development Manager at Regis Medical, a Germany-based medical device distributor, and earlier worked in HSBC's Leveraged & Acquisition Finance group in New York and as an analyst in HSBC's London office covering M&A and IPOs. He holds an Hon. B.A. in Economics from the University of Toronto.
Contact· self-published, not guessed
Invests in
Medical Devices
Board director at R3 Vascular
Intro paths
In turn, Frederik can intro founders to R3 Vascular's investors below.
R3 Vascular's investors · 1
Co-founders at R3 Vascular
Experience
- 415 CapitalCo-Founder & Managing Partnercurrent2018 — presentMunich, Bavaria, Germany
- R3 Vascular Inc.Director Board Of Directorscurrent2020 — presentMountain View, California, United States
- TRiCares GmbHMember of the Supervisory Boardcurrent2022 — presentAschheim, Germany & Paris, France
- CorFlowBoard Observercurrent2021 — presentBaar, Zug, Switzerland
- DistalmotionBoard Observercurrent2021 — presentLausanne, Vaud, Switzerland
- Cardiac Success Ltd.Director Board Of Directors2021 — 2024Yoqneam Illit, North District, Israel
- CardioMech ASDirector Board Of Directors2019 — 2020Trondheim, Trøndelag, Norway
- Regis MedicalDirector Of Business Development2016 — 2018Oberhaching, Bavaria, Germany
- HSBC Global Banking and MarketsSenior Associate2011 — 2016New York, New York
Skills & more
+8 more
LBOEquitiesMergers & AcquisitionsBloomberg TerminalLeveraged FinanceDCFVenture CapitalMedtechLanguages English · German
From Frederik's professional profile.
Deals · 4
DistalmotionLed round
via 415 Capital
TRiCares GmbH and SASLed round
via 415 Capital
Cardiac SuccessLed round
via 415 Capital
CorflowLed round
via 415 Capital
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
AktiiaR3 VascularSupira
Board seats
R3 Vascular
Per the firm's website.
Colleagues at 415 Capital
Network5
Investors connected to Frederik in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Frederik Groenewegen?
- Frederik Groenewegen is a co-founder and General Partner of 415C, focusing on medical technology investments. Before starting the firm, he was a Business Development Manager at Regis Medical, a Germany-based medical device distributor, and earlier worked in HSBC's Leveraged & Acquisition Finance group in New York and as an analyst in HSBC's London office covering M&A and IPOs. He holds an Hon. B.A. in Economics from the University of Toronto.
- Where does Frederik Groenewegen work?
- Frederik Groenewegen is General Partner at 415 Capital and Board director at R3 Vascular.
- What does Frederik Groenewegen invest in?
- Frederik Groenewegen invests in Medical Devices.
- What check size does Frederik Groenewegen write?
- Frederik Groenewegen typically writes checks of $100K – $5M.
- What boards does Frederik Groenewegen sit on?
- Frederik Groenewegen holds tracked board seats at R3 Vascular, TRiCares GmbH and SAS.
- What companies has Frederik Groenewegen invested in?
- Investments tracked here include Aktiia, Cardiac Success, Corflow, Distalmotion, R3 Vascular, Supira, TRiCares GmbH and SAS.
- Where did Frederik Groenewegen go to school?
- Frederik Groenewegen studied at University of Toronto; University of Toronto - University College (Hon. B.A., Double major in Economics and History); Lyceum Alpinum Zuoz.
- Does Frederik Groenewegen lead rounds?
- Yes — Frederik Groenewegen has led 7 tracked investments.
Same school
Also attended University of Toronto341
+ 335 more
